Expedition Medicines
PrivateLast Round
Series A
Oct 22, 2025
Total Funding Raised
$50M
Company Overview
Expedition Medicines is a biotechnology company that is building an AI platform to expand the boundaries of medicine by generating small molecule drugs against disease-driving proteins that have long been considered undruggable.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Precision Medicine, Medical AI, ML Platforms
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Expedition Medicines Comps
Public and private peers based on sector, stage, and business model.
Expedition Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 22, 2025 |
Expedition Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
$50M Series A round completed.
Expedition Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Expedition Medicines's valuation, stock price, and market status.
